A

AnMed Health IMA | Ambulatory Research

Research site
(Unclaimed)
Location
2000 E Greenville St Suite 3850, Anderson, South Carolina, United States of America
Site insights

Top conditions

Diabetes Mellitus (2 trials)

Type 2 Diabetes Mellitus (2 trials)

Top treatments

Sugar
Cagrilintide
Metformin

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 2
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)

This study is comparing the medicine RYBELSUS® to other medicines in people with type 2 diabetes who need extra treatment. All medicines used in this...

Enrolling
Diabetes Mellitus, Type 2
Drug: oral glucose-lowering medications (commercially available)
Drug: semaglutide

The study will look at how well CagriSema helps people lower their blood sugar and body weight. CagriSema is a new weekly medicine that combines two...

Enrolling
Type 2 Diabetes Mellitus
Drug: Cagrilintide
Drug: Semaglutide

Trial sponsors

Novo Nordisk logo

Novo Nordisk (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems